secwatch.observer — SEC 8-K summary
======================================

Issuer:     Kyverna Therapeutics, Inc. (KYTX)
CIK:        0001994702
Form:       8-K
Filed at:   2024-02-12T23:59:59+00:00
Accession:  0001193125-24-032161
Event type: other_material
Sentiment:  positive
Materiality: 0.85
Item codes: 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Kyverna Therapeutics completes IPO of 16.7M shares at $22.00, gross proceeds $366.9M
--------------------------------------------------------------------------------

- Gross proceeds $366.9M from IPO including full exercise of underwriter option to purchase 2.175M additional shares.
- Shares listed on Nasdaq Global Select Market under ticker KYTX.
- Amended charter and bylaws effective upon closing include classified board, exclusive forum provisions, and no cumulative voting.
- Authorized capital: 490M shares of common stock and 10M shares of undesignated preferred stock.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1994702/000119312524032161/0001193125-24-032161-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1994702/000119312524032161/d765670d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-032161

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer